Effects of Subminimal Inhibitory Concentrations of Chlorhexidine on the Chlorhexidine Resistance and Biofilm Formation in Clinical Drug-resistant Acinetobacter baumannii Isolates
DOI:
https://doi.org/10.25156/ptj.v12n2y2022.pp85-91Keywords:
Acinetobacter baumannii, Chlorhexidine, Biofilm, MultiresistantAbstract
Background and objectives: Multi-drug resistant microorganisms have caused a remarkable increase in hospital-acquired infections (HAI) during the previous few decades. Moreover, microbiological contamination of antiseptics and disinfectants has been recorded in medical settings.
Methods: A total of 61 clinically relevant Acinetobacter baumannii isolates were collected from various clinical specimens in hospitals in Erbil city/Iraq between September 2021 and March 2022. The isolates were identified using VITEK-2 compact system. Antimicrobial susceptibility testing was carried out for a total of 16 different therapeutically relevant antibiotics in accordance with the criteria of the Clinical Laboratory Standards Institute (CLSI) using the above mentioned system. A spectrophotometer was used to determine the optical density at 600 nm (OD600nm) for biofilm evaluation. Wilcoxon signed ranks test used to determine the effect of sub-MIC of CHX on the CHX-MIC and biofilm formation.
Results: the study showed that there is a significant difference in CHX-MIC and biofilm formation before and after 7 days of incubation of Acinetobacter baumannii in sub-MIC of CHX (p<0.05). Exposure of Acinetobacter baumannii to sub-lethal CHX concentrations develops inducible resistance to lethal CHX doses. The biofilm formation ability of isolates also increased after using sub-lethal dose of CHX.
Downloads
References
A'SHIMI, M. H. N., ALATTRAQCHI, A. G., RANI, F. M., RAHMAN, N. I. A., ISMAIL, S., ABDULLAH, F. H., OTHMAN, N., CLEARY, D. W., CLARKE, S. C. & YEO, C. C. 2019. Biocide susceptibilities and biofilm-forming capacities of Acinetobacter baumannii clinical isolates from Malaysia. The Journal of Infection in Developing Countries, 13, 626-633.
AKHLAGHI, N., SADEGHI, M., FAZELI, F., AKHLAGHI, S., MEHNATI, M. & SADEGHI, M. 2019. The antibacterial effects of coffee extract, chlorhexidine, and fluoride against Streptococcus mutans and Lactobacillus plantarum: An in vitro study. Dental research journal, 16, 346.
AL-GHAZALY, N. & TUWAIJ, N. 2022. Distribution of AmpC-Family genes among Acinetobacter spp isolates in Najaf City, Iraq. International journal of health sciences.
AMSALU, A., SAPULA, S. A., DE BARROS LOPES, M., HART, B. J., NGUYEN, A. H., DRIGO, B., TURNIDGE, J., LEONG, L. E. & VENTER, H. 2020. Efflux pump-driven antibiotic and biocide cross-resistance in Pseudomonas aeruginosa isolated from different ecological niches: A case study in the development of multidrug resistance in environmental hotspots. Microorganisms, 8, 1647.
APISARNTHANARAK, A., HSU, L. Y., LIM, T.-P. & MUNDY, L. M. 2014. Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control. Infection Control & Hospital Epidemiology, 35, 98-99.
AZIZ, R. A. R. & AL-JUBORI, S. S. 2017. Molecular analysis of genetic elements responsible for XDR in highly successful pathogen Acinetobacter baumannii isolated from clinical samples of Iraqi patients. J Glob Pharma Technol, 9, 26-39.
BALAURE, P. C. & GRUMEZESCU, A. M. 2020. Recent advances in surface nanoengineering for biofilm prevention and control. Part II: active, combined active and passive, and smart bacteria-responsive antibiofilm nanocoatings. Nanomaterials, 10, 1527.
BISWAS, D., TIWARI, M. & TIWARI, V. 2019. Molecular mechanism of antimicrobial activity of chlorhexidine against carbapenem-resistant Acinetobacter baumannii. PloS one, 14, e0224107.
CARUSO, C., PORTA, A., TOSCO, A., ELETTO, D., PACENTE, L., BARTOLLINO, S. & COSTAGLIOLA, C. 2020. A Novel vitamin E TPGS-based formulation enhances chlorhexidine bioavailability in corneal layers. Pharmaceutics, 12, 642.
CHIANG, S.-R., JUNG, F., TANG, H.-J., CHEN, C.-H., CHEN, C.-C., CHOU, H.-Y. & CHUANG, Y.-C. 2018. Desiccation and ethanol resistances of multidrug resistant Acinetobacter baumannii embedded in biofilm: The favorable antiseptic efficacy of combination chlorhexidine gluconate and ethanol. Journal of Microbiology, Immunology and Infection, 51, 770-777.
CIEPLIK, F., JAKUBOVICS, N. S., BUCHALLA, W., MAISCH, T., HELLWIG, E. & AL-AHMAD, A. 2019. Resistance toward chlorhexidine in oral bacteria–is there cause for concern? Frontiers in microbiology, 10, 587.
CLINICAL & INSTITUTE, L. S. 2015. M100-S25 Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement. CLSI, 35, 1-240.
FUANGTHONG, M., JULOTOK, M., CHINTANA, W., KUHN, K., RITTIROONGRAD, S., VATTANAVIBOON, P. & MONGKOLSUK, S. 2011. Exposure of Acinetobacter baylyi ADP1 to the biocide chlorhexidine leads to acquired resistance to the biocide itsel and to oxidants. Journal of Antimicrobial Chemotherapy, 66, 319-322.
HASHEMI, M. M., HOLDEN, B. S., COBURN, J., TAYLOR, M. F., WEBER, S., HILTON, B., ZAUGG, A. L., MCEWAN, C., CARSON, R. & ANDERSEN, J. L. 2019. Proteomic analysis of resistance of Gram-negative bacteria to chlorhexidine and impacts on susceptibility to colistin, antimicrobial peptides, and ceragenins. Frontiers in microbiology, 10, 210.
HOUARI, A. & DI MARTINO, P. 2007. Effect of chlorhexidine and benzalkonium chloride on bacterial biofilm formation. Letters in applied microbiology, 45, 652-656.
JAIN, N., JANSONE, I., OBIDENOVA, T., SIMANIS, R., MEISTERS, J., STRAUPMANE, D. & REINIS, A. 2021. Antimicrobial Resistance in Nosocomial Isolates of Gram-Negative Bacteria: Public Health Implications in the Latvian Context. Antibiotics, 10, 791.
KING, L. B., SWIATLO, E., SWIATLO, A. & MCDANIEL, L. S. 2009. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunology & Medical Microbiology, 55, 414-421.
LIU, W. J., FU, L., HUANG, M., ZHANG, J. P., WU, Y., ZHOU, Y. S., ZENG, J. & WANG, G. X. 2017. Frequency of antiseptic resistance genes and reduced susceptibility to biocides in carbapenem-resistant Acinetobacter baumannii. Journal of medical microbiology, 66, 13-17.
MAGIORAKOS, A.-P., SRINIVASAN, A., CAREY, R. B., CARMELI, Y., FALAGAS, M., GISKE, C., HARBARTH, S., HINDLER, J., KAHLMETER, G. & OLSSON-LILJEQUIST, B. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical microbiology and infection, 18, 268-281.
NATH, S., SINHA, A., SINGHA, Y. S., DEY, A., BHATTACHARJEE, N. & DEB, B. 2020. Prevalence of antibiotic-resistant, toxic metal-tolerant and biofilm-forming bacteria in hospital surroundings. Environmental Analysis, Health and Toxicology, 35.
NOWAK, J., ZANDER, E., STEFANIK, D., HIGGINS, P. G., ROCA, I., VILA, J., MCCONNELL, M. J., CISNEROS, J. M., SEIFERT, H. & WP4, M. W. G. 2017. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. Journal of Antimicrobial Chemotherapy, 72, 3277-3282.
ORTEGA‐PEÑA, S., HIDALGO‐GONZÁLEZ, C., ROBSON, M. C. & KRÖTZSCH, E. 2017. In vitro microbicidal, anti‐biofilm and cytotoxic effects of different commercial antiseptics. International Wound Journal, 14, 470-479.
RAJAMOHAN, G., SRINIVASAN, V. & GEBREYES, W. A. 2009. Biocide-tolerant multidrug-resistant Acinetobacter baumannii clinical strains are associated with higher biofilm formation. Journal of Hospital Infection, 73, 287-289.
RANGEL, K., CHAGAS, T. P. G. & DE-SIMONE, S. G. 2021. Acinetobacter baumannii infections in times of COVID-19 pandemic. Pathogens, 10, 1006.
RÖHNER, E., JACOB, B., BÖHLE, S., ROHE, S., LÖFFLER, B., MATZIOLIS, G. & ZIPPELIUS, T. 2020. Sodium hypochlorite is more effective than chlorhexidine for eradication of bacterial biofilm of staphylococci and Pseudomonas aeruginosa. Knee Surgery, Sports Traumatology, Arthroscopy, 1-7.
SALEHI, B., GOUDARZI, H., NIKMANESH, B., HOURI, H., ALAVI-MOGHADDAM, M. & GHALAVAND, Z. 2018. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. Journal of infection and chemotherapy, 24, 515-523.
SEHREE, M. M., ABDULLAH, H. N. & JASIM, A. M. 2021. Isolation and Evaluation of Clinically Important Acinetobacter Baumannii From Intensive Care Unit Samples. Journal of Techniques, 3, 83-90.
ŞIMŞEK, M. & DEMIR, C. 2020. Determination of colistin and tigecycline resistance profile of acinetobacter baumannii strains from different clinical samples in a territory hospital in Turkey. Journal of Health Science and Medical Research, 38, 81-91.
SMAI, S. B. 2020. A Prevalence of infections with antibiotic-resistant Acinetobacter baumannii in different clinical samples from hospitals in Erbil. Zanco Journal of Pure and Applied Sciences, 32, 95-100.
SOBOUTI, B., MIRSHEKAR, M., FALLAH, S., TABAEI, A., MEHRABADI, J. F. & DARBANDI, A. 2020. Pan drug-resistant Acinetobacter baumannii causing nosocomial infections among burnt children. Medical journal of the Islamic Republic of Iran, 34, 24.
THEURETZBACHER, U. 2017. Global antimicrobial resistance in Gram-negative pathogens and clinical need. Current opinion in microbiology, 39, 106-112.
TOKAJUK, G., NIEMIROWICZ, K., DEPTUŁA, P., PIKTEL, E., CIEŚLUK, M., WILCZEWSKA, A. Z., DĄBROWSKI, J. R. & BUCKI, R. 2017. Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity. International journal of nanomedicine, 12, 7833.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Hawkar S. Omer, Safaa T. Aka
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).